Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023
31 Outubro 2023 - 5:05PM
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing
and precision medicine, will hold its third quarter earnings
conference call on Monday, November 6, 2023 at 4:30 p.m. EDT. The
company’s quarterly earnings will be released the same day after
the market closes.
During the call, Myriad management will provide a financial
overview and business update of the company’s performance for the
third quarter 2023.
Conference Call and Webcast The dial-in
number for domestic callers is 1-800-771-6781. International
callers may dial 1-212-231-2900. All callers will be asked to
reference reservation number 22028316. An archived replay of the
call will be available for seven days by dialing 1-800-633-8284 and
entering the reservation number above. The conference call and
slide presentation will be available through a live webcast at
www.myriad.com.
About Myriad GeneticsMyriad Genetics is a
leading genetic testing and precision medicine company dedicated to
advancing health and well-being for all. Myriad develops and offers
genetic tests that help assess the risk of developing disease or
disease progression and guide treatment decisions across medical
specialties where genetic insights can significantly improve
patient care and lower healthcare costs. For more information,
visit www.myriad.com.
Media
Contact: |
Investor Contact: |
Glenn Farrell |
Matt Scalo |
(385) 318-3718 |
(801) 584-3532 |
PR@myriad.com |
IR@myriad.com |
Myriad Genetics (NASDAQ:MYGN)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Myriad Genetics (NASDAQ:MYGN)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024